What makes a scientist truly great? For Peter Davies, it's what he did with his discoveries. He developed the antibodies that helped define Alzheimer's pathology, then gave them away freely to researchers worldwide. Labs & Labyrinths tells that story ➡️ newvisionresearch.org/peter-davies...
Charleston Conference on Alzheimer's Disease (CCAD)
@the-ccad.bsky.social
Transforming the way medical research is funded by investing in early-career researchers with innovative ideas. #CCAD
Every scientific breakthrough has a story. Labs and Labyrinths celebrates the life and legacy of Dr. Peter Davies whose curiosity, collaboration, & groundbreaking discoveries helped shape modern Alzheimer's research. Discover the story behind the science: newvisionresearch.org/peter-davies...
"A fitting tribute to a wonderful friend and colleague." — Alison Goate, DPhil Discover the life, science, and legacy of Alzheimer's research pioneer Dr. Peter Davies in Labs and Labyrinths. newvisionresearch.org/peter-davies... #PeterDavies #AlzheimersResearch #Neuroscience
Dr. Davies helped shape the foundations of modern Alzheimer’s research, with work that continues to influence the field today. His contributions were not only scientific, but deeply collaborative. His story is preserved in Labs and Labyrinths. Explore the book: newvisionresearch.org/peter-davies...
The latest issue of CCAD Connections is live! This edition features a CCAD Research Focus by Jaroslav Bendl, highlights from NIH-funded CCAD alumni, and a look back at the Book Launch & Symposium honoring Dr. Peter Davies. Explore the full issue here ➡️ www.flipsnack.com/ccadreport/j...
His neighbors knew him as the kind man in the Pink Floyd T-shirt who loved his garden. The scientific world knew him as the researcher whose discoveries helped produce the 1st treatments for Alzheimer's disease. Labs & Labyrinths tells both sides of that story newvisionresearch.org/peter-davies...
What makes a scientist truly great? For Peter Davies, it was what he did with his discoveries. He developed the antibodies that helped define Alzheimer's pathology, then gave them away freely to researchers worldwide. Labs & Labyrinths tells that story ➡️ newvisionresearch.org/peter-davies...
Only a few days left! CCAD 2027 nominations close Monday, June 29. Don't miss the opportunity to recognize an exceptional early-career Alzheimer's researcher. Nominate now: airtable.com/appjJE7FUGZY...
The countdown is on! CCAD 2027 nominations close June 29. Help us identify the next generation of leaders in Alzheimer’s research by submitting a nomination today ➡️ airtable.com/appjJE7FUGZY...
CCAD 2027 nominations are open! Help us identify the next generation of early-career Alzheimer’s researchers making an impact. Nomination links have been sent via email or you can scan the QR code to submit today!
Peter Davies helped shape Alzheimer's research, but those who knew him remember much more than his scientific achievements. "This book recounts the life of a great scientist and a humble man." -Dr. Goate Learn about Peter's life, work, and lasting legacy: newvisionresearch.org/peter-davies...
A meaningful evening at The New York Academy of Medicine for the launch of Labs and Labyrinths, honoring Alzheimer’s researcher Peter Davies. Grateful to Melissa Murray and Ben Wolozin for sharing reflections on his scientific legacy. The book is now available for purchase at newvisionresearch.org
LAST CALL! Join us TODAY at 1 PM ET for a conversation on mentorship and lab culture with Srikant Rangaraju, Derek Archer, Andrea Weinstein, and Joseph Castellano. Register NOW: us02web.zoom.us/meeting/regi...
Congratulations, @chloelopezlee.bsky.social of Mount Sinai, a 2026 New Vision Investigator Awardee. Her $100K, 2-year grant supports research on why women maintain cognitive function despite early Alzheimer’s changes, and how those protective mechanisms could inform future therapies. #CCAD2026
Congratulations Melissa Cooper, PhD of NYU Langone Health, a 2026 New Vision Research Awardee! Her $100K grant will fund “Astrocyte Networks in Alzheimer’s Disease” exploring how brain cell networks drive disease and reveal new therapies. #CCAD2026 #AlzheimersResearch
One week away! Don’t miss our next Zoom Your Career webinar 4/13 at 1 PM EST, all about mentorship and creating a positive lab culture. Register now ➡️ us02web.zoom.us/meeting/regi...
The Charlie Dorego Travel Award celebrates the energy, humor, and connection that define CCAD. Congrats to Alexander Parker, PhD of Vanderbilt University for bringing all three to #CCAD2026 👏 #AlzheimersResearch #TravelAwardee
Our next Zoom Your Career webinar is happening in just a few weeks! Join us April 13 at 1 PM EST for a conversation on mentorship and building a healthy lab culture. Register now ➡️ us02web.zoom.us/meeting/regi...
The Peter Davies Travel Award honors the most collaborative investigator at CCAD. Someone who brings both scientific excellence and generosity of spirit. This year, that was Jian Hu, PhD, of Emory University. Congratulations, Dr. Hu! 🎉 #AlzheimersResearch #CCAD2026
Our next Zoom Your Career webinar is coming up! Join us 4/13 at 1PM EST for a conversation on mentorship and building healthy lab culture. Scan the QR code to register or the link ➡️ us02web.zoom.us/meeting/regi...
Congratulations to Andy Tsai, PhD, of Stanford University, 2026 recipient of the George Bartzokis Travel Award! This honor recognizes a bold thinker who challenges convention and pushes Alzheimer's research forward with intellectual courage. Well deserved, Dr. Tsai! #AlzheimersResearch #CCAD2026
Join us on 4/13 at 1 PM ET for our next Zoom Your Career webinar! You will hear from Srikant Rangaraju, along side Derek Archer and Andrea Weinstein, with Joseph Castellano moderating the conversation. Register ➡️ us02web.zoom.us/meeting/regi...
Another year, another photo on the steps at The Charleston Place.The 2026 CCAD cohort is officially alumni! We are grateful for this ever-growing community of #CCADAlumni.
Help us give a big round of applause to the CCAD 2026 Awardees 👏 Read more in our press release ➡️ bit.ly/46FJ5Lq
We are incredibly grateful to @live5news.com and reporter Caroline Spikes for highlighting the work of the Charleston Conference on Alzheimer’s Disease. Supporting early-career scientists isn’t just something we talk about, it is at the heart of who we are. www.live5news.com/2026/02/27/l...
Lowcountry researchers provide grants to researchers for Alzheimer’s studies
The National Institutes of Health has seen funding cuts that could leave local Alzheimer’s research at a standstill, but smaller grants are giving some researchers a chance to continue their work.
live5news.com
Nothing says Charleston like an evening at Bowens Island Restaurant! After a full day of presentations, oysters and a Lowcountry boil were the perfect way to unwind and connect outside the conference room. 🦪 🦐 #CCAD2026
Last night’s Meet & Greet brought together investigators and mentors dedicated to advancing Alzheimer’s disease research. A reminder of what makes the Charleston Conference on Alzheimer’s Disease community so special! #CCAD2026
TODAY at 1 PM ET! There's still time to register. Join us for a conversation about Translational Science: Bridging Research and Clinical Practice. 🔬 Please note: Webinar will not be recorded. Register now ➡️ us02web.zoom.us/meeting/regi...
New work from our lab! Link: rdcu.be/e0sfU 𝗧𝗮𝘂 𝗛𝗶𝗷𝗮𝗰𝗸𝘀 𝗕𝗿𝗮𝗶𝗻 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘀𝗺, 𝗗𝗿𝗶𝘃𝗶𝗻𝗴 𝗦𝗹𝗲𝗲𝗽 𝗟𝗼𝘀𝘀 𝗶𝗻 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 A quick thread on our findings!
Tau pathology reprograms glucose metabolism to support cortical hyperexcitability, excitatory/inhibitory imbalance, and sleep loss
npj Dementia - Tau pathology reprograms glucose metabolism to support cortical hyperexcitability, excitatory/inhibitory imbalance, and sleep loss
rdcu.be
From discovery to clinical practice. Join us on Feb 9 at 1PM ET for our next Zoom Your Career webinar on Translational Science. Register-> us02web.zoom.us/meeting/regi...